Skip to content

America Great Health: 10-Q filed 2025-05-15

What America Great Health reported in its quarterly report filed 2025-05-15 (fiscal Q3 2025): 43 published measures, 125 facts as tagged in accession 0001185185-25-000484.

This filing

Form
10-Q (quarterly report)
Filed
2025-05-15
Fiscal period
fiscal Q3 2025
Accession
0001185185-25-000484 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All America Great Health filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-03-31266,993USD
At 2024-06-30323,478USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-03-315,976,602USD
At 2024-06-305,635,077USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-03-31-5,626,992USD
At 2024-06-30-5,231,105USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-158,399USD90
2024-07-01 to 2025-03-31-496,923USD274
2024-01-01 to 2024-03-31-226,550USD91
2023-07-01 to 2024-03-31-631,227USD275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-07-01 to 2025-03-31-60,297USD274
2023-07-01 to 2024-03-31-450,200USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-01-01 to 2025-03-3156,148USD90
2024-07-01 to 2025-03-31287,213USD274
2024-01-01 to 2024-03-3194,032USD91
2023-07-01 to 2024-03-31199,019USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-07-01 to 2025-03-3143,314USD274
2023-07-01 to 2024-03-31447,486USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-03-31-10,745,604USD
At 2024-06-30-10,248,681USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-01-01 to 2025-03-3121,150,711,608shares90
2024-07-01 to 2025-03-3121,141,529,720shares274
2024-01-01 to 2024-03-3121,133,108,023shares91
2023-07-01 to 2024-03-3121,118,741,702shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD/shares90
2024-07-01 to 2025-03-310USD/shares274
2024-01-01 to 2024-03-310USD/shares91
2023-07-01 to 2024-03-310USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD/shares90
2024-07-01 to 2025-03-310USD/shares274
2024-01-01 to 2024-03-310USD/shares91
2023-07-01 to 2024-03-310USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-01-01 to 2025-03-310USD90
2024-01-01 to 2024-03-310USD91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-03-3131,812USD
At 2024-06-3042,903USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-85,319USD90
2024-07-01 to 2025-03-31-276,692USD274
2024-01-01 to 2024-03-31-134,262USD91
2023-07-01 to 2024-03-31-363,067USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-03-31196,192USD
At 2024-06-30225,479USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-03-313,708,534USD
At 2024-06-303,593,468USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-03-3136,900USD
At 2024-06-3055,100USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-03-31107,356USD
At 2024-06-3083,141USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-01-01 to 2025-03-3149,817USD90
2024-07-01 to 2025-03-31261,705USD274
2024-01-01 to 2024-03-3182,111USD91
2023-07-01 to 2024-03-31178,396USD275

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-01-01 to 2025-03-31135,136USD90
2024-07-01 to 2025-03-31538,397USD274
2024-01-01 to 2024-03-31216,373USD91
2023-07-01 to 2024-03-31541,463USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-03-3121,150,711,608shares
At 2024-06-3021,136,888,326shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-03-3136,880USD
At 2024-06-3054,943USD
At 2024-03-3151,739USD
At 2023-06-3054,150USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-03-315,121,175USD
At 2024-06-305,019,059USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2025-03-31-2,563USD
At 2024-06-30-1,483USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-03-31-5,709,609USD
At 2024-12-31-5,576,377USD
At 2024-09-30-5,389,271USD
At 2024-06-30-5,311,599USD
At 2024-03-31-4,718,783USD
At 2023-12-31-4,623,268USD
At 2023-09-30-4,525,038USD
At 2023-06-30-4,370,836USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-03-3127,153USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2025-03-312,060,036USD
At 2024-06-301,833,577USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-03-3142,131USD
At 2024-06-3031,040USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-03-3127,153USD
At 2024-06-3043,260USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-03-3115,056USD
At 2024-06-3032,295USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2025-03-3165,410USD
At 2024-06-3059,600USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2025-03-318,423,280USD
At 2024-06-307,924,234USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-158,377USD90
2024-07-01 to 2025-03-31-499,046USD274
2024-01-01 to 2024-03-31-228,507USD91
2023-07-01 to 2024-03-31-634,833USD275

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-158,377USD90
2024-07-01 to 2025-03-31-499,046USD274
2024-10-01 to 2024-12-31-193,702USD92
2024-07-01 to 2024-09-30-146,967USD92
2024-01-01 to 2024-03-31-228,507USD91
2023-07-01 to 2024-03-31-634,833USD275
2023-10-01 to 2023-12-31-249,345USD92
2023-07-01 to 2023-09-30-156,980USD92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-158,254USD90
2024-07-01 to 2025-03-31-498,003USD274
2024-01-01 to 2024-03-31-226,184USD91
2023-07-01 to 2024-03-31-630,924USD275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-03-31120,881USD90
2024-07-01 to 2025-03-31500,948USD274
2024-01-01 to 2024-03-31212,375USD91
2023-07-01 to 2024-03-31540,791USD275

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2024-07-01 to 2025-03-3111,091USD274
2023-07-01 to 2024-03-3111,092USD275

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-01-01 to 2025-03-3173,059USD90
2024-07-01 to 2025-03-31222,394USD274
2024-01-01 to 2024-03-3194,267USD91
2023-07-01 to 2024-03-31271,802USD275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-01-01 to 2025-03-31-73,058USD90
2024-07-01 to 2025-03-31-222,354USD274
2024-01-01 to 2024-03-31-94,245USD91
2023-07-01 to 2024-03-31-271,766USD275

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-07-01 to 2025-03-31102,116USD274
2023-07-01 to 2024-03-31286,582USD275

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2024-07-01 to 2025-03-3161,916USD274
2023-07-01 to 2024-03-3150,793USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-07-01 to 2025-03-31-18,200USD274
2023-07-01 to 2024-03-3169,800USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2024-07-01 to 2025-03-3124,215USD274
2023-07-01 to 2024-03-3124,788USD275

Inspect the source

Entity
America Great Health / CIK 0001098009
Captured
2026-09-20T05:22:41.750Z
SEC response SHA-256
d8f662fbd420a341966c110b708cf158efd7ace2a37734663adbc1ac1ab23238

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001098009.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))